학술논문
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study
Document Type
Article
Author
Source
In World Allergy Organization Journal January 2020 13(1)
Subject
Language
ISSN
1939-4551